Prior investigation by Moccia et al. in COVID-19 patients showed that non-survivors had a higher level of IL-6 as well as higher rates of acute cardiac injury and acute heart failure, suggesting that IL-6 potentially contributes to development of myocardial injury in COVID-19 patients (9). Here, IL6 is linked to COVID-19.